UnitedHealth (UNH) used aggressive tactics to collect payment-boosting diagnoses for Medicare Advantage members, according to a Senate committee, The Wall Street Journal’s Christopher Weaver reports. The company’s internal documents revealed strategies like diagnosing conditions without confirmation and incentivizing doctors for potential diagnoses. UnitedHealth faces several investigations into its practices, including civil and criminal probes by the Justice Department that the company disclosed in July. Shares of UnitedHealth are down over 1% in premarket trading.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth Reaffirms 2025 EPS Outlook to Investors
- UnitedHealth (UNH) Under Fire for Using Aggressive Tactics to Boost Medicare Payments
- Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
- Arista, RTX, CoreWeave, Shopify, UNH Trending With Analysts
- Option traders moderately bearish in UnitedHealth with shares down 0.49%
